Franklin-McKinley School District, CA's GO SPUR Raised To 'A+' Jun 08

  • ID: 1752247
  • June 2008
  • Standard & Poors
1 of 3

SAN FRANCISCO (Standard & Poor's) June 17, 2008--Standard & Poor's Ratings Services raised its underlying rating (SPUR) to 'A+' from 'A' on Franklin-McKinley School District, Calif.'s outstanding general obligation (GO) bonds, and raised its SPUR to 'A' from 'A-' on the district's outstanding certificates of participation (COPs). In addition, Standard & Poor's assigned its 'A+' rating to the district's $7.365 million series 2008 GO refunding bonds. The outlook is stable. "The raised rating reflects the district's continued strong tax base growth and good fund balances after three challenging years marked by budget cuts and deficits," said Standard & Poor's credit analyst Paul Dyson. "The district's tax base has also expanded in recent years, with assessed value that has increased at...

Companies mentioned in this report are:
- Franklin-McKinley Sch Dist

Action: New Rating
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Franklin-McKinley Sch Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.